Cala Health Claims to Have the only Patented Neurostimulation for Essential Tremor Treatment. The Patent Data Disagrees
April 15, 2021
Cala Health has figured out that innovations backed by patents make them exponentially more valuable in the marketplace. However, in a zest for promotion, it might have exaggerated a bit. In early April 2021, Cala Health had 2 patent…
Google AI Reinvents Speech Recognition. Who will follow?
April 1, 2021
There is no doubt that the big 5 tech companies (Apple, Amazon, Google, Facebook, and Microsoft) have developed massive IP portfolios in many areas - except perhaps one. For example, of the big 5, only Google has patent data in the…
Sony is Exploring the AI/Biotech Diagnostics Sector. Ask us how we know.
March 25, 2021
When people think of Sony products, they usually think of audio, visual, and storage devices. That is because a majority of Sony's products fall into one of these categories. However, Sony's recent patent activity suggests that it may be…
Apex Neuro Inventions May Be Poised to Impact the Neuromodulation Field
March 11, 2021
Investment in patents always leads market activity. So Apex Neuro's investments in key research and development implicate its positioning for market launch in the coming years. So far, Patent Forecast shows 5 patent assets from Apex Neuro…
Neurology Companies Take Note: A New Data Management Player has Entered the Field
March 4, 2021
On February 25th, a new competitor joined the increasingly crowded space in the Neurology Sector. Rune Labs, a San Francisco-based biotech startup had 4 applications published. Each of these documents teach a system or method related to…
The First Company to use Genomic Data for Fitness Recommendations. Should other Companies Take Note?
February 25, 2021
There is no doubt that improved technologies have greatly reduced the amount of time necessary to sequence human genomes. In the past, it would take weeks or even months to sequence a single person's genome. Modern technology has greatly…
Are Insurance Companies the Next Entrants to the Neurology Sector?
February 18, 2021
The neurology sector has traditionally been led by large tech-focused companies such as IBM, Boston Scientific, and Phillips Inc. That being said, occasionally we also see companies not traditionally considered “tech” companies receive…
Should Google or Amazon be Eyeing Frontive? Should You be Eyeing Frontive?
February 11, 2021
When it comes to in-home voice assistants, there are two clear leaders: Amazon and Google. Both of these Big Five technology companies offer a variety of options from either the Google Home or Amazon Echo product lines. Now that both…
You’ll get a kick out of this
February 4, 2021
Sufferers of Restless Leg Syndrome (RLS) will tell you that there is nothing worse than trying to fall asleep with restless legs. The disorder, which affects nearly 3 million people annually in the US, is characterized by a nearly…
Patent data fills in the cracks where Google data lacks
January 28, 2021
This past week, Neurostim OAB Inc. had two more patent applications published in the AI Biotech/Diagnostic sector. This brings their total document count to 10 applications, all of which were published after April 2020. While simply…
Movano holds the missing key for‚”Apple?‚”Samsung?
January 21, 2021
This past week, Movano Inc. had its 3rd patent issued. The patent, U.S. Pat. No. 10,888,242, teaches a method and system of monitoring various health parameters from a small sensor embedded into a smartphone case. Notably, the sensor…
Patent Data as an Early Warning of New Competitors
January 14, 2021
Well-organized patent data can really make a difference for your company. One of the most powerful benefits of patent data is that it allows you to better understand your competitor landscape. Most established companies know who the big…
When Sectors Collide: Cannabis meets AI Biotech/Diagnostics
January 7, 2021
There is no doubt that our interest in cannabis has grown in recent years. Every week we see new patent data in our Cannabis Patent Forecast® that indicates that many companies are developing awesome new technologies associated with…
Using Patent Data to Make Sense of Seemingly Questionable Business Deals
January 7, 2021
Although there are numerous benefits to monitoring patent data, one of the most important involves staying up to date with what your competitors are doing. The right data can be especially useful to help understand why a competitor makes a…
Honda joins Toyota, GM and Affectiva in the race to build mood-sensing vehicles
December 17, 2020
This past week, Japanese car maker Honda Motor Co., Ltd. became the most recent vehicle manufacturer to gain IP in the Neurology Sector. However, while fresh IP is usually a good sign for a company, one might question whether investing in…
Cranial Prosthesis with Ultrasound Compatibility
December 10, 2020
Ultrasound is often a preferred imaging method due to its low cost, and lack of dangerous radiation, but it is unable to penetrate bone, and therefore cannot be used to monitor the brain. Gliaview's newest invention looks to address this…
Boston Scientific Gains Slight Edge for 2020 Lead in AI-Neurology IP
December 10, 2020
With the issuance of US Pat. No. 10,842,997, Boston Scientific has gained a small lead in the AI Biotech: Neurology sector as the end of 2020 draws near. The ‘997 patent is the 13th patent granted to Boston Scientific in the Neurology…
Thought Beanie invests in mood detection. Apple, Facebook & Amazon ignores. Uh oh…
December 3, 2020
The idea of monitoring a wearers mood has been around for a long time (think back to the mood rings you had in middle school), but a quick look at the AI Biotech/Diagnostics: Neurology Sector seems to indicate that there is still a large…
Using Neurostimulation to Replace Chemical Anti-Depressants
October 28, 2020
This past week, biotech-startup Inner Cosmos LLC had its first patent application publish (US Pat. Pub. No. 20200330749), and in doing so, joined the ever-growing neurostimulation market. The California-based startup is currently working…
Mental State Detection: Samsung Capitalizes while Apple Lags
October 22, 2020
This week, Samsung had its fourth Patent (U.S. Patent No. 10,803,389) publish in the Mental State sector of the AI Biotech/Diagnostic radian. In addition to its four patents, Samsung also has 2 pending applications in the sector. This most…
Detecting Shoppers’ Mental States While Shopping
October 15, 2020
It's no secret that retailers want to better understand how their customers think while shopping in their stores. Knowing what a shopper thinks of things such as store layout, pricing, advertisements, and cleanliness would allow the…
Philips Continues to Lead the Way in Sleep Neurology
October 7, 2020
Philips Electronics' most recent patent application (US Pub. 2020306494) proves they are still the leaders in the Sleep portion of the AI Biotech: Neurology sector. The '6494 application teaches a method that monitors a user's electrical…
Boston Scientific Invests in Ablation Systems to Treat Atrial Fibrillation
September 30, 2020
Boston Scientific has just announced that they have signed an investment deal that includes a later acquisition option with medical-device startup Farapulse Inc. The California-based startup is currently pending FDA-approval for a number…
Wearable Monitor to Assess Joint Health
September 23, 2020
Have you ever wondered if the sound of your knees cracking when you stand up from your desk after a few hours is a normal sound part of aging, or maybe the result of something more sinister? KneeVoice Inc.'s newest patent application (U.S.…
Battelle – the Newest Entrant in the Neuromodulation Field?
September 16, 2020
Battelle Memorial Institute is slowly building an IP portfolio in the AI Biotech/Diagnostic Sector. This past week, the Ohio-based nonprofit had its second application in the neurology sector publish. The application (U.S. Pat. No.…